Guangdong Association of Integrative Medicine

Contents

Preface ...........................................................................................................................................................52

Introduction ....................................................................................................................................................53

1 Scope .......................................................................................................................................................54

2 Normative References ..............................................................................................................................54

3 Etiological Characteristics ........................................................................................................................55

4 Epidemiologic Features ............................................................................................................................55

5 Pathological Changes ..............................................................................................................................55

6 Clinical Characteristics .............................................................................................................................56

7 Cause and Mechanism in views of Traditional Chinese Medicine ...........................................................57

8 Diagnosis ..................................................................................................................................................57

9 Differential Diagnosis ...............................................................................................................................59

10 The Discovery and Reporting of Infected Cases ....................................................................................59

11 Prevention and Treatment with Traditional Chinese and Western Medicine ..........................................59

References .....................................................................................................................................................68

Preface

This consensus was drafted in accordance with the rules stipulated inGB/T1.1-2009 Directives for Standardization Part 1: Structure and Drafting Standards.

This consensus was put forward by Guangdong Association of Integrative Medicine.

Expert consulting panel:

XUAN Guo-wei (禤國(guó)維), ZHOU Dai-han (周岱翰), QIU Jian-xing (邱健行), WANG Sheng-liang (王省良),WANG Xinhua (王新華)

Principal drafters:

GUO Jiao (郭姣), LIU Xiaohong (劉小虹), LI Aimin (李愛(ài)民), XIE Bing (謝兵), ZHANG Zhong-de (張忠德),ZHANG Wei (張偉), LIN Lin (林琳), TAN Jie (譚杰)

Experts participating in the drafting consensus:

DING Bang-han (丁邦晗), MA Wei (馬為), WANG Chang-jun (王昌俊), LU Wen-ju (盧文菊), YE Yan (葉焰),LV Zhi-ping (呂志平), LIU Lei (劉磊), LIU Jian-bo (劉建博), JIANG Yong (江勇), ZHUANG Hong-fa(莊轟發(fā)), XU Pu-sheng (許浦生), XU Yin-ji (許銀姬), LI Yi (李藝) LI Ji-qiang(李際強(qiáng)), YANG Jian-xin (楊建新),XIAO Bo (肖波), WU Jian (吳健), HE Jin (何金), HE Ming-feng (何明豐), HE De-ping (何德平) , YU Xi-yong (余細(xì)勇), ZHANG Shi-jun (張?jiān)娷?, ZHANG Rong-hua( 張榮華), JIN Shi-ming (金世明), ZHOU Yu-qi (周宇麒),ZHOU Hong-mei (周紅梅), ZHOU Ji-hong (周繼紅), ZHENG Xiao-he ( 鄭小河), ZHENG Xue-bao (鄭學(xué)寶),HONG Ming-fan (洪銘范), HE Ai-hui (賀愛(ài)輝) , XIA Xin-tian (夏欣田), XU Hong (徐虹), XU Wei-fang (徐衛(wèi)方),TANG Ke-jing (唐可京), PENG Ying (彭英), CHENG Yuan-xiong (程遠(yuǎn)雄) , FU Nan-lin(傅南琳), WEN Min-yong(溫敏勇), XIE Xia-nan (謝夏南), ZHAN Shao-feng (詹少鋒), CAI Yan (蔡彥), WEI Cheng-gong (魏成功)

Secretariats:

JIN Ying-hua (金英花), XIANG Lei (項(xiàng)磊)

Correspondence to:GUO Jiao (1961.11-), female, Ph.D., Professor, Chief Physician, Qihuang scholar, President of Guangdong Association of Integrative Medicine; Vice president of Chinese Association of Integrative Medicine. E-mail:gyguoyz@163.com.

Introduction

Coronavirus Disease 2019 (here in after referred as the COVID-19), as an acute respiratory infectious disease, has been de fined as a Category B infectious disease according to theLaw of the People's Republic of China on the Prevention and Treatment of Infectious Diseases, and is treated as a Category A infectious disease. On January 19, 2020, Guangdong Province confirmed its first imported COVID-19 Case. On January 23,Guangdong Province launched the highest-level response to major public health emergencies. The next day, Traditional Chinese Medicine Bureau of Guangdong Province issued theTreatment of COVID-19 by Chinese Medicine of Guangdong Province(Trial Version I), which provides a guideline for the intervention and prevention of COVID-19 with traditional Chinese medicine. However,the diagnosis and treatment of COVID-19 with integrated traditional Chinese and Western medicine is lack of guidance. In order to further implement the important instructions of General Secretary Xi Jinping, the decisions and arrangements of the Party Central Committee, the State Council and the provincial government, and the guidance of the Central Leading Group on Responding to COVID-19 Outbreak on "strengthening the integration of traditional Chinese and Western medicine, promoting the in-depth involvement of traditional Chinese medicine in the whole process of disease diagnosis and treatment, and promoting effective prescriptions and ready-for-use traditional Chinese medicine in a timely manner", Guangdong Association of Integrative Medicine follows the national diagnosis and treatment scheme of COVID-19, fully absorbs the treatment experience of domestic and foreign counterparts, and adheres to the strategy of integrating traditional Chinese and Western medicine to tackle the problem. On February 18, the meetings of the president and secretary general of Guangdong Association of Integrative Medicine agreed unanimously to organize experts to compileExpert Consensus of Guangdong Province on Prevention and Treatment of COVID-19 by Integrated Chinese and Western Medicine, (Trial Version I). Professor Guo Jiao,president of Guangdong Association of Integrative Medicine, led the experts in the field of integrated traditional Chinese and Western medicine, the chairman, vice-chairman and members of the respiratory diseases committees, chronic obstructive pulmonary diseases committees and other related professional committees of Guangdong Association of Integrative Medicine, and a number of experts in the field of traditional Chinese and Western medicine who are working at the anti-epidemic frontline in Wuhan, Jingzhou and other places in Hubei Province. Together, they form groups of consulting experts, principal drafters, consensus experts and a secretariat to discuss and determine the target groups, target users, consensus structure, scope and theme of the consensus. The established goals are as follows: improve the success rate of clinical treatment of COVID-19 by integrating traditional Chinese and Western medicine, reduce the mortality rate, prevent disease beforehand, diagnose and treat them at an early stage, block the progress of the disease, reduce the proportion of seriously ill patients, speed up the recovery of patients, discuss the prevention and treatment methods of integrated traditional Chinese and Western medicine in curing COVID-19 and reach a consensus.

Due to the urgency of the drafting task and epidemic control, this expert consensus was compiled by referring to the WHO's rapid advice guidelines for public health emergency events. On the basis of theDiagnosis and Treatment Plan of COVID-19(Trial Version VII) issued by the National Health Commission and National Administration of Traditional Chinese Medicine, and theTreatment of COVID-19 by Chinese Medicine of Guangdong Province(Trial Version II) issued by the Health Commission and the Traditional Chinese Medicine Bureau of Guangdong Province, the consensus summarizes the experience of clinical frontline application of integrated traditional Chinese and Western medicine in the diagnosis and treatment of COVID-19. Taking the climate characteristics and residents' physiques in Lingnan area of Guangdong Province into consideration, the consensus adheres to the principle of integrating traditional Chinese and Western medicine in disease diagnosis and treatment, and refine and optimize the treatment scheme. The principal drafters first wrote the first draft of the consensus. The consensus expert group crossexamined and revise the first draft independently. The secretariat and the secretariat office of Association assisted in collecting the opinions. The principal drafters discussed and agreed on the revised version of the text in combination with the opinions of consensus experts. The speci fic method is as follows:the opinions for revision put forward by 3 or more experts directly entered into the revised text; after discussion and deliberation by the principal drafters,the remaining amendments were decided whether to be adopted or not. Finally, the final opinions were solicited from experts again in the form of "face-toface (video conference)" to formExpert Consensus of Guangdong Province on Prevention and Treatment of COVID-19 by Integrated Chinese and Western Medicine(Trial Version I).